Cardinal Health, Inc. $CAH Shares Sold by Bridgewater Advisors Inc.

Bridgewater Advisors Inc. cut its holdings in Cardinal Health, Inc. (NYSE:CAH) by 3.8% during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 22,005 shares of the company’s stock after selling 874 shares during the period. Bridgewater Advisors Inc.’s holdings in Cardinal Health were worth $3,441,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently bought and sold shares of CAH. Greykasell Wealth Strategies Inc. acquired a new stake in Cardinal Health in the first quarter valued at $26,000. Jones Financial Companies Lllp raised its stake in Cardinal Health by 198.3% in the first quarter. Jones Financial Companies Lllp now owns 21,112 shares of the company’s stock valued at $27,000 after buying an additional 14,034 shares in the last quarter. Atlantic Edge Private Wealth Management LLC raised its stake in Cardinal Health by 75.0% in the second quarter. Atlantic Edge Private Wealth Management LLC now owns 175 shares of the company’s stock valued at $29,000 after buying an additional 75 shares in the last quarter. GW&K Investment Management LLC raised its stake in Cardinal Health by 113.4% in the first quarter. GW&K Investment Management LLC now owns 271 shares of the company’s stock valued at $37,000 after buying an additional 144 shares in the last quarter. Finally, Harbor Asset Planning Inc. acquired a new stake in Cardinal Health in the second quarter valued at $49,000. 87.17% of the stock is currently owned by institutional investors and hedge funds.

Cardinal Health Trading Up 0.4%

Shares of CAH opened at $190.65 on Monday. Cardinal Health, Inc. has a twelve month low of $107.11 and a twelve month high of $197.67. The stock’s 50 day moving average is $155.17 and its two-hundred day moving average is $154.65. The firm has a market capitalization of $45.29 billion, a PE ratio of 29.56, a P/E/G ratio of 1.39 and a beta of 0.71.

Cardinal Health (NYSE:CAH) last posted its quarterly earnings results on Thursday, October 30th. The company reported $2.55 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.22 by $0.33. Cardinal Health had a net margin of 0.70% and a negative return on equity of 74.45%. The company had revenue of $64.01 billion during the quarter, compared to the consensus estimate of $59.41 billion. During the same period last year, the firm earned $1.88 EPS. The company’s revenue for the quarter was up 22.4% on a year-over-year basis. Cardinal Health has set its FY 2026 guidance at 9.650-9.850 EPS. On average, sell-side analysts predict that Cardinal Health, Inc. will post 7.95 EPS for the current year.

Cardinal Health Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Wednesday, October 15th. Stockholders of record on Wednesday, October 1st were given a dividend of $0.5107 per share. This represents a $2.04 dividend on an annualized basis and a dividend yield of 1.1%. The ex-dividend date was Wednesday, October 1st. Cardinal Health’s dividend payout ratio (DPR) is presently 30.77%.

Wall Street Analysts Forecast Growth

A number of analysts have recently commented on CAH shares. Evercore ISI lifted their target price on Cardinal Health from $190.00 to $220.00 and gave the stock an “outperform” rating in a research report on Friday. Jefferies Financial Group set a $150.00 target price on Cardinal Health in a research report on Tuesday, August 12th. Leerink Partners lifted their target price on Cardinal Health from $187.00 to $211.00 in a research report on Friday. Robert W. Baird set a $232.00 price target on Cardinal Health in a report on Friday. Finally, Citigroup raised their price target on Cardinal Health from $165.00 to $190.00 and gave the stock a “neutral” rating in a report on Friday. Twelve analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $176.87.

Insider Activity at Cardinal Health

In related news, CEO Stephen M. Mason sold 41,575 shares of Cardinal Health stock in a transaction that occurred on Tuesday, August 19th. The stock was sold at an average price of $148.82, for a total transaction of $6,187,191.50. Following the completion of the transaction, the chief executive officer directly owned 26,085 shares in the company, valued at $3,881,969.70. The trade was a 61.45% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, insider Michelle D. Greene sold 13,500 shares of Cardinal Health stock in a transaction that occurred on Tuesday, August 19th. The stock was sold at an average price of $148.82, for a total value of $2,009,070.00. Following the transaction, the insider owned 14,976 shares of the company’s stock, valued at $2,228,728.32. This represents a 47.41% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last 90 days, insiders sold 271,676 shares of company stock worth $40,489,525. 0.12% of the stock is currently owned by company insiders.

Cardinal Health Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.